This symposium will cover the transition from drug discovery into drug development and will draw together the views of key opinion leaders from both fields of research. It is an opportunity to learn the views from pharmaceutical industry on what defines a lead candidate and the pre-clinical process through which compounds must succeed prior to nomination for clinical development.